首页> 美国卫生研究院文献>Drug Design Development and Therapy >Novel purine thioglycoside analogs: synthesis nanoformulation and biological evaluation in in vitro human liver and breast cancer models
【2h】

Novel purine thioglycoside analogs: synthesis nanoformulation and biological evaluation in in vitro human liver and breast cancer models

机译:新型嘌呤硫代糖苷类似物:体外人肝癌和乳腺癌模型中的合成纳米制剂和生物学评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: A series of novel pyrazolopyrimidine and pyrazololpyridine thioglycosides were synthesized and confirmed via their spectral analyses.>Purpose: To evaluate the effect of these anti-metabolic compounds against proliferation of Huh-7 and Mcf-7 as in vitro models of human liver and breast cancers, respectively. Vero cells were used as an example of normal green monkey kidney cells.>Methods: The most promising compound was subjected to a nanoformulation by its encapsulation into chitosan nanoparticles to increase its anti-cancerous activity. Nanoformulation was confirmed by TEM and FT-IR to ensure encapsulation and screened for their cytotoxicity against Huh-7 and Mcf-7 cells using MTT colorimetric assay and morphological examination. Genotoxic effect was performed by cellular DNA fragmentation assay. Simulated CompuSyn software (linear interaction effect) was conducted to predict the possible synergistic effect of nanocomposite as anticancerous activity. Apoptotic effect was further analyzed by detection of apoptotic proteins using ELISA assay.>Results: The nano preparation was successfully prepared by encapsulation of compound 14 into chitosan nanoparticles, controlled to a size at 105 nm and zeta charges at 40.2 mV. Treatment of Huh-7 and Mcf-7 showed that compound 14 was the most cytotoxic compound on both cancer cell lines where IC50 was 24.59 (9.836 μg/mL) and 12.203 (4.8812 μg/mL) on Huh-7 and Mcf-7 respectively. But IC50 of the nano preparation was 37.19 and 30.68 μg/mL on Huh-7 and Mcf-7, respectively, indicating its aggressiveness on human breast cancer cells as confirmed by DNA fragmentation assay and theoretically by CompuSyn tool.>Conclusion: A novel series of pyrazolopyrimidine thioglycosides and pyrazolopyridine thioglycosides were synthesized. Nanoformulation of compound 14 into chitosan nanoparticles demonstrated anticancer activity and can be used as a drug delivery system, but further studies are still required.
机译:>背景:合成了一系列新颖的吡唑并嘧啶和吡唑并吡啶硫代糖苷,并通过其光谱分析证实。>目的:目的评估这些抗代谢化合物对Huh- 7和Mcf-7分别作为人类肝癌和乳腺癌的体外模型。以Vero细胞为例,它是正常的绿猴肾细胞。>方法:通过将其封装到壳聚糖纳米颗粒中以提高其抗癌活性,对最有前途的化合物进行了纳米配方。通过TEM和FT-IR确认了纳米制剂以确保包封,并使用MTT比色法和形态学检查筛选了它们对Huh-7和Mcf-7细胞的细胞毒性。遗传毒性作用通过细胞DNA片段测定法进行。进行了模拟的CompuSyn软件(线性相互作用效应)以预测纳米复合材料作为抗癌活性可能产生的协同效应。通过使用ELISA分析检测凋亡蛋白,进一步分析了细胞凋亡的作用。>结果:通过将化合物14封装到壳聚糖纳米颗粒中成功制备了纳米制剂,将其控制在105 nm的大小,zeta电荷控制在40.2毫伏对Huh-7和Mcf-7的处理表明,化合物14是两种癌细胞系中最具细胞毒性的化合物,其中Huh-7和Mcf-7的IC50分别为24.59(9.836μg/ mL)和12.203(4.8812μg/ mL)。 。但是该纳米制剂在Huh-7和Mcf-7上的IC50分别为37.19和30.68μg/ mL,表明通过DNA片段测定法和CompuSyn工具从理论上证实了其对人乳腺癌细胞的侵袭性。>结论:< / strong>合成了一系列新颖的吡唑并嘧啶硫代糖苷和吡唑并吡啶硫代糖苷。将化合物14纳米配制为壳聚糖纳米颗粒具有抗癌活性,可以用作药物递送系统,但仍需要进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号